Conference Coverage

VIDEO: Don’t overlook psychosocial concerns of vitiligo patients


 

EXPERT ANALYSIS FROM AAD 17

– There are ways to assess the psychosocial needs of your patients with vitiligo, even if you don’t believe you have the necessary skills to do a complete mental health work-up, according to Seemal R. Desai, MD.

In an interview recorded at this year’s annual meeting of the American Academy of Dermatology, Dr. Desai, an assistant clinical professor of dermatology at the University of Texas, Dallas, shares his ideas for how to have casual conversations with patients that can help reveal important clues to psychosocial stress patients with this serious medical skin condition might be facing.

“There are subtle clues to look for to know that these patients are uncomfortable with others seeing their skin,” says Dr. Desai.

In the video interview, he also covers taking a multidisciplinary approach to caring for these patients, what treatments are available to those who are suffering psychosocial stress after having failed several interventions, and how patients from many Asian and African counties are especially at risk for ostracization.

“It’s important to let your patients know that you understand this is really affecting them psychosocially, and that you care,” says Dr. Desai.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

Tips on how to differentiate CLE from dermatomyositis
MDedge Family Medicine
Mycophenolate puts lupus patients in remission faster than azathioprine
MDedge Family Medicine
Prenatal exposure to hydroxychloroquine cuts risk of neonatal cutaneous lupus
MDedge Family Medicine
Lupus patients may be shortchanged on lipid management
MDedge Family Medicine
VIDEO: Pattern recognition provides clues to rheumatologic diagnoses
MDedge Family Medicine
Pediatric lupus patients face large burden of serious infection
MDedge Family Medicine
Connective tissue diseases reported in patients receiving immune checkpoint inhibitors
MDedge Family Medicine
For bullous pemphigoid, doxycycline noninferior to prednisolone, but safer
MDedge Family Medicine